BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24372145)

  • 21. Serial Crystallography for Structure-Based Drug Discovery.
    Zhu L; Chen X; Abola EE; Jing L; Liu W
    Trends Pharmacol Sci; 2020 Nov; 41(11):830-839. PubMed ID: 32950259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cryo-EM in drug discovery: achievements, limitations and prospects.
    Renaud JP; Chari A; Ciferri C; Liu WT; Rémigy HW; Stark H; Wiesmann C
    Nat Rev Drug Discov; 2018 Jul; 17(7):471-492. PubMed ID: 29880918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Essential considerations for using protein-ligand structures in drug discovery.
    Warren GL; Do TD; Kelley BP; Nicholls A; Warren SD
    Drug Discov Today; 2012 Dec; 17(23-24):1270-81. PubMed ID: 22728777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. X-ray crystallography: Assessment and validation of protein-small molecule complexes for drug discovery.
    Cooper DR; Porebski PJ; Chruszcz M; Minor W
    Expert Opin Drug Discov; 2011 Aug; 6(8):771-782. PubMed ID: 21779303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-throughput quantum-mechanics/molecular-mechanics (ONIOM) macromolecular crystallographic refinement with PHENIX/DivCon: the impact of mixed Hamiltonian methods on ligand and protein structure.
    Borbulevych O; Martin RI; Westerhoff LM
    Acta Crystallogr D Struct Biol; 2018 Nov; 74(Pt 11):1063-1077. PubMed ID: 30387765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. '
    Chakraborti S; Hatti K; Srinivasan N
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The R-factor gap in macromolecular crystallography: an untapped potential for insights on accurate structures.
    Holton JM; Classen S; Frankel KA; Tainer JA
    FEBS J; 2014 Sep; 281(18):4046-60. PubMed ID: 25040949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Difficult macromolecular structures determined using X-ray diffraction techniques.
    Hernández-Santoyo A
    Protein Pept Lett; 2012 Jul; 19(7):770-7. PubMed ID: 22489779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The SGC beyond structural genomics: redefining the role of 3D structures by coupling genomic stratification with fragment-based discovery.
    Bradley AR; Echalier A; Fairhead M; Strain-Damerell C; Brennan P; Bullock AN; Burgess-Brown NA; Carpenter EP; Gileadi O; Marsden BD; Lee WH; Yue W; Bountra C; von Delft F
    Essays Biochem; 2017 Nov; 61(5):495-503. PubMed ID: 29118096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein crystallography for non-crystallographers, or how to get the best (but not more) from published macromolecular structures.
    Wlodawer A; Minor W; Dauter Z; Jaskolski M
    FEBS J; 2008 Jan; 275(1):1-21. PubMed ID: 18034855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening Ligands by X-ray crystallography.
    Davies DR
    Methods Mol Biol; 2014; 1140():315-23. PubMed ID: 24590727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining temperature perturbations with X-ray crystallography to study dynamic macromolecules: A thorough discussion of experimental methods.
    Thompson MC
    Methods Enzymol; 2023; 688():255-305. PubMed ID: 37748829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural biology and drug discovery.
    Scapin G
    Curr Pharm Des; 2006; 12(17):2087-97. PubMed ID: 16796557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cryo-electron microscopy and X-ray crystallography: complementary approaches to structural biology and drug discovery.
    Vénien-Bryan C; Li Z; Vuillard L; Boutin JA
    Acta Crystallogr F Struct Biol Commun; 2017 Apr; 73(Pt 4):174-183. PubMed ID: 28368275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Personal remarks on the future of protein crystallography and structural biology.
    Jaskolski M
    Acta Biochim Pol; 2010; 57(3):261-4. PubMed ID: 20725645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. X-ray diffraction experiment--the last experiment in the structure elucidation process.
    Chruszcz M; Borek D; Domagalski M; Otwinowski Z; Minor W
    Adv Protein Chem Struct Biol; 2009; 77():23-40. PubMed ID: 20663480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein crystallography for aspiring crystallographers or how to avoid pitfalls and traps in macromolecular structure determination.
    Wlodawer A; Minor W; Dauter Z; Jaskolski M
    FEBS J; 2013 Nov; 280(22):5705-36. PubMed ID: 24034303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. XModeScore: a novel method for accurate protonation/tautomer-state determination using quantum-mechanically driven macromolecular X-ray crystallographic refinement.
    Borbulevych O; Martin RI; Tickle IJ; Westerhoff LM
    Acta Crystallogr D Struct Biol; 2016 Apr; 72(Pt 4):586-98. PubMed ID: 27050137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A public database of macromolecular diffraction experiments.
    Grabowski M; Langner KM; Cymborowski M; Porebski PJ; Sroka P; Zheng H; Cooper DR; Zimmerman MD; Elsliger MA; Burley SK; Minor W
    Acta Crystallogr D Struct Biol; 2016 Nov; 72(Pt 11):1181-1193. PubMed ID: 27841751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bridging Crystal Engineering and Drug Discovery by Utilizing Intermolecular Interactions and Molecular Shapes in Crystals.
    Spackman PR; Yu LJ; Morton CJ; Parker MW; Bond CS; Spackman MA; Jayatilaka D; Thomas SP
    Angew Chem Int Ed Engl; 2019 Nov; 58(47):16780-16784. PubMed ID: 31385643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.